REVAMPING PNEUMONIA DIAGNOSIS AND ANTIMICROBIAL STEWARDSHIP WITH ADVANCED MOLECULAR DIAGNOSTICS
Tuesday 19 July 2022
19:30-20:30 Singapore time (UTC+8)
An educational initiative sponsored by bioMérieux
This webinar has ended.
TOPIC
Revamping Pneumonia Diagnosis and Antimicrobial Stewardship with Advanced Molecular Diagnostics
OUTLINE
This webinar presents the latest clinical practices of infectious disease management topics followed by an open discussion for healthcare professionals across Asia Pacific for medical educational purpose. This episode will demonstrate real-world case presentations by international physicians speaking about their experiences of patient management and value-based diagnostic stewardship.
What You Will Learn
Latest evolution of diagnostic practices with clinical cases of non-ICU Community-Acquired Pneumonia, Ventilator-Acquired Pneumonia and COVID-19 Pneumonia.
Case 1: Prescribing antibiotics for every CAP?
Case 2: Treating older patients of multiple comorbidities, including COPD
Case 3: When vancomycin/piperacillin-tazobactam is not enough
Case 4: COVID-19 and VAP
The implementation of new, rapid, multiplex PCR diagnostics and care of pneumonia patients, helping medical practitioners feel less stressful and more confident in managing patients suspected of lower respiratory tract infections during the pandemic.
FORMAT
Welcome and Introduction from the APSR
Welcome from the BioMerieux
Presentation
・40 minutes for Presentation
・5 minutes Summary and Conclusions
・5 minutes Q&AClosing Remarks from the APSR
SPEAKERS
Dr Tufik Assad
Medical Director of Critical Care Unit, Williamson Medical Center
U.S.A
SPEAKER
Dr David C L Lam
President
APSR
Hong Kong
OPENING, CLOSING REMARKS
Dr Yuanlin Song
Head
APSR Respiratory Infections (non-TB) Assembly
China